Geneva, Feb. 23 -- International Clinical Trials Registry received information related to the study (ACTRN12626000194369) titled 'A study to assess the safety of increasing single doses of AP003 in healthy adults' on Feb. 16.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Primary Sponsor: Alltrna, Incorporated
Condition:
Liver stop codon disease
Arg-TGA premature termination codon mutations
Liver-associated inborn errors of metabolism
Genetic diseases
Liver stop codon disease
Arg-TGA premature termination codon mutations
Liver-associated inborn errors of metabolism
Genetic diseases
Metabolic and Endocrine - Metabolic disorders
Human Genetics and Inherited Disorders - Other huma...